Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Trupanion reports robust 2022 growth, eyes international expansion opportunities

Trupanion delivered strong financial performance in 2022, with significant revenue and income growth driven by pet acquisitions and retention strategies.
The company's focus on efficient capital deployment, expansion into new channels, and cash reserve position it well for future growth and profitability.
While facing challenges from pricing dynamics and international expansion, Trupanion's strategic initiatives present opportunities for sustained growth and market expansion.
With a positive outlook for 2023 and a solid foundation of customer data, Trupanion is poised to leverage its strengths and navigate challenges for continued success.

Trupanion reports robust Q1 earnings, eyes global expansion opportunities

Trupanion's Q1 2023 earnings call showcased strong financial performance, strategic focus on managing challenges related to inflation, and opportunities for global expansion and market growth. The company's effective pricing strategies and emphasis on long-term vision position it well for revenue growth and margin expansion in 2023.

Trupanion reports robust Q2 performance, eyes growth opportunities ahead

Trupanion's Q2 2023 performance reflects strong revenue growth, margin stabilization, and strategic cost management.
The company aims for disciplined growth, margin expansion, and sustained ARPU amidst challenges in revenue diversification and cost optimization.
Opportunities lie in continued rate increases, marketing efficiency improvements, and enhanced reporting for customer engagement and financial performance.

Trupanion reports robust Q3 earnings, eyes disciplined growth strategies

Trupanion's Q3 performance reflects strong revenue growth, margin expansion, and improved cash flow, underpinned by pricing power and customer loyalty.
While facing challenges in diversifying revenue streams and entering new markets, the company is well-positioned to leverage growth opportunities and maintain financial stability.
With a focus on disciplined growth, operational efficiency, and strategic investments, Trupanion aims to sustain positive momentum and capitalize on the growing pet insurance market.

Trupanion reports robust Q4 growth, focuses on margin expansion

Trupanion's Q4 performance reflects resilience amid industry challenges, with a strong focus on sustainable growth and financial discipline. The company's strategic initiatives to enhance member experience, prioritize margin expansion, and optimize capital deployment position it well for future opportunities.

Trupanion reports robust Q1 performance amidst market challenges and opportunities

Trupanion's Q1 2024 performance reflects strong revenue growth, margin expansion, and operational improvements driven by customer-centric strategies and efficient capital deployment.
While facing challenges such as inflation impacts and remediation efforts, the company's focus on margin expansion, market opportunities, and strategic initiatives positions it for future growth.
Investors can be optimistic about Trupanion's ability to navigate challenges, capitalize on growth opportunities, and drive profitability through effective pricing and operational efficiency.

Trupanion reports robust Q3 performance, eyes growth opportunities in Europe

Trupanion's Q3 performance reflects strong growth in subscription income and strategic initiatives to drive profitability and market expansion.
While challenges persist with inflation and cost management, the company's focus on efficiency and growth presents opportunities for sustained success.
Investors should note the positive operational improvements, the strategic market expansion into Europe, and the commitment to achieving sustainable margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

LOS ANGELES, CA / ACCESSWIRE / July 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Trupanion, Inc. ("Trupanion" or "the Company") (NASDAQ:TRUP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm

NEW YORK , July 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trupanion, Inc. ("Trupanion" or the "Company") (NASDAQ: TRUP). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trupanion, Inc. - TRUP

SEATTLE, July 13, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2023 second quarter after the market closes on Thursday, August 3rd, 2023. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.

Trupanion, Inc. Announces Second Quarter 2023 Earnings Release and Conference Call

Mr. Brodén Brings Global Financial Acumen and Continues Ongoing Refreshment of Board Mr. Brodén Brings Global Financial Acumen and Continues Ongoing Refreshment of Board

Trupanion Appoints Aflac Incorporated CFO Max Brodén to Board of Directors

SEATTLE, June 30, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) today issued the following statement on its New York rate filing status:

Trupanion Provides Statement on New York Rate Filing Status

As shareholders of pet insurer Trupanion Inc. NASDAQ: TRUP learned last month, when you post a net loss that's twice what Wall Street expected, things get a little fuzzy.

Down Over 80%, is Pet Insurer Trupanion Worth the Risk Premium?

Trupanion (TRUP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Trupanion (TRUP) Moves 9.9% Higher: Will This Strength Last?

Vet inflation has impacted Trupanion's performance. But it got great news on Thursday afternoon: Rate increases were approved in key states.

Why Trupanion Stock Dropped 15.6% This Week

GlaxoSmithKline

Virgin Galactic

Shares of Trupanion Inc. TRUP, -5.73% jumped 16% in premaket trading after the pet-insurance provider announced that California and New York approved double-digit rate increases, saying that the hikes were “necessary in today's rising cost of veterinary care environment.”

Virgin Galactic shares tumble, while Trupanion and GSK climb and other stocks on the move

Markets mostly finished higher after a sluggish start to the day. 3M announced a tentative settlement with public water suppliers over alleged PFAS contamination.

These 2 Stocks Are Jumping Big After Hours Thursday

Shares of Trupanion Inc. TRUP, -5.73% jumped after hours on Thursday after the pet-insurance provider announced that California and New York approved double-digit rate increases, saying that the hikes were “necessary in today's rising cost of veterinary care environment.” California approved a rate increase of more than 12%, while New York approved a requested 18% rate increase, the company said.

New York, California OK rate increases for pet insurance provider Trupanion, and investors cheer

SEATTLE, June 22, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) today provided the following updates on its rate filing approval status in California and New York:

Trupanion Provides Updates on Rate Filing Approval Status in California and New York

SEATTLE, June 15, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that Darryl Rawlings, Chief Executive Officer, will participate in meetings with investors at the Jefferies 2023 Consumer Conference in Nantucket, Massachusetts on June 20-21, 2023.

Trupanion to Participate in the Jefferies 2023 Consumer Conference

As part of the initiative, Trupanion pledges to gift $10,000 worth of scrubs to the veterinary community As part of the initiative, Trupanion pledges to gift $10,000 worth of scrubs to the veterinary community

Trupanion Launches ‘truthankyou' Program to Celebrate the Unsung Heroes of the Veterinary Community

Trupanion, a pet insurance provider, is currently undervalued by 15.5% with a fair value of $27.15, according to a discounted cash flow valuation and relative valuation. The company aims for aggressive scale growth to capture the expanding pet insurance market, with a focus on customer retention and integrated capabilities. These factors and the company's undervaluation lead me to rate the firm a 'buy'

Trupanion Continues To Scale And Lead The Medical Pet Insurance Industry

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Trupanion, Inc. ("Trupanion" or "the Company") (NASDAQ:TRUP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm

SEATTLE, May 25, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that Darryl Rawlings, Chief Executive Officer, and Margi Tooth, President, will participate in a fireside chat at the Stifel 2023 Jaws & Paws Conference in New York on Thursday, June 1, 2023 at 3:00 pm ET and will participate in meetings with investors throughout the day.

Trupanion to Present at the Stifel 2023 Jaws & Paws Conference

LOS ANGELES, CA / ACCESSWIRE / May 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Trupanion, Inc. ("Trupanion" or "the Company") (NASDAQ:TRUP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 23, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Trupanion, Inc. ("Trupanion" or "the Company") (NASDAQ:TRUP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm

Cinemark Holdings

Editas Medicine

World Acceptance

Beyond Meat

Chewy

The Beauty Health Company

A practice designed for only the most daring traders, the best short-squeeze stocks to buy now could yield tremendous gains. To be sure, approaching this sector means staring at the possibility of severe losses in the face.

7 Short-Squeeze Stocks Set for a May Rally

Trupanion logged huge growth in its enrolled pets in the first quarter. The company has the financial resources to keep growing.

Trupanion's Sales Are Surging on Puppy Love That Should Have Growth Investors Salivate

LOS ANGELES--(BUSINESS WIRE)---- $TRUP #TRUP--The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm

Trupanion (NASDAQ: TRUP ) stock is coming under pressure today. This morning, short seller Marc Cohodes attacked the pet insurance company in a tweet.

Short Sellers Are Taking Aim at Trupanion (TRUP) Stock

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Trupanion, Inc. and Encourages Investors with Losses to Contact the Firm

Trupanion (NASDAQ: TRUP ) stock is taking a beating on Friday after the pet medical insurance company released its earnings report for the first quarter of 2023. The bad news for TRUP stock comes from its diluted earnings per share of -60 cents.

News for Trupanion Stock (TRUP)